Cite
MLA Citation
Anne Thomas et al.. “Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma.” European journal of cancer, vol. 124, 2020, pp. 131–141. http://access.bl.uk/ark:/81055/vdc_100098075050.0x000031